Showing 2,662 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Novartis' Certican succeeds in liver transplant trial

Editor's pick
Reuters
12 November 2012
New & experimental hepatitis C treatment

AASLD-GI-5005 Improves Virologic Clearance of HCV in Combination with PegIFN/Ribavirin in IL28B T/T Patients

Editor's pick
HCV New Drugs Research
12 November 2012
New & experimental hepatitis C treatment

Abbott interferon-free combination 'promising' in harder-to-treat patients with hepatitis C

News
12 November 2012
New & experimental hepatitis C treatment

High rate of response to BMS HCV drugs in harder-to-treat patients – but interferon-free prospects differ by sub-genotype

News
12 November 2012
New & experimental hepatitis C treatment

Final study results show telaprevir is safe and effective for HIV/HCV co-infected people

News
12 November 2012
New & experimental hepatitis C treatment

Gilead, Abbott Unwrap Dueling Hep C Pill Data

Editor's pick
The Street
12 November 2012
New & experimental hepatitis C treatment

New hepatitis C drugs danoprevir and mericitabine are safe and effective for prior non-responders and people with cirrhosis

News
12 November 2012
Hepatitis C symptoms & diagnosis

New cohort shows the impact of hepatitis B and hepatitis C on the 'baby boom' generation

News
11 November 2012
New & experimental hepatitis C treatment

ALS-2200 (VX-135), Vertex's Oral Nucleotide Analogue in Development for Hepatitis C

Editor's pick
Vertex press release
11 November 2012
New & experimental hepatitis C treatment

Twice-Daily Telaprevir Achieved Viral Cure (SVR12) Rates Similar to Those Treated Three Times Daily

Editor's pick
Vertex press release
11 November 2012
Cancer

The connection between Fatty Liver Disease and the Increase in the Rate of Liver Cancer

Editor's pick
AASLD press release
11 November 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim to start late-stage hepatitis C drug trial

Editor's pick
Reuters
11 November 2012
New & experimental hepatitis C treatment

Idenix Reports On IDX719 and IDX184

Editor's pick
Idenix press release
11 November 2012
Hepatitis C transmission & prevention

Hepatitis C-Safeguarding the Medical Injection Process

Editor's pick
HCV New Drugs Research
10 November 2012
People who inject drugs

UK: HPA report found half of people who inject drugs are infected with hepatitis C, one in 100 have HIV

Editor's pick
Health Protection Agency
10 November 2012
Hepatitis C transmission & prevention

Europe Fails to Screen its Population for Hepatitis

Editor's pick
PR Newswire
8 November 2012
Hepatitis C transmission & prevention

UK lags behind Germany France and Slovenia in international index on hepatitis care performance

Editor's pick
Hepatitis C Trust
8 November 2012
New & experimental hepatitis C treatment

Copy of Merck will initiate interferon-free Phase II clinical trials for MK-5172, an investigational, once-daily, oral treatment for chronic hepatitis C virus

Editor's pick
Merck press release
6 November 2012
New & experimental hepatitis C treatment

Merck will initiate interferon-free Phase II clinical trials for MK-5172, an investigational, once-daily, oral treatment for chronic hepatitis C virus

Editor's pick
Merck press release
6 November 2012
Hepatitis C transmission & prevention

Hepatits C could be eliminated from cities, leading specialist says

Editor's pick
GP Online
5 November 2012
New & experimental hepatitis C treatment

Avoiding Missteps When Evaluating New HCV Trial Data

Editor's pick
Clinical Care Options (requires registration)
5 November 2012
Pharmaceutical industry

Gilead and the Pharmasset Deal: Do the Ends Justify the Means?

Editor's pick
PropThink
5 November 2012
Access to healthcare

Hope for hep-c patients: Patients succeed in overturning first ever product patent on medicine in India

Editor's pick
Lawyers' Collective
2 November 2012
Access to healthcare

IPAB revokes patent on Roche Hepatitis C drug

Editor's pick
Hindu Business Line
2 November 2012